click below
click below
Normal Size Small Size show me how
Carroll U Pharm 1
Stack #147067
| Question | Answer |
|---|---|
| Effectiveness | elicits responses for which it has been administered. |
| Safety | drug does not produce a harmful effect over extended period of time. |
| Selectivity | elicits only those responses for which it is given, not such thing. |
| Pharmacokinetics | study of drug absorption, distribution in the body, metabolism in the liver and kidneys, and excretion. |
| Pharmacodynamics | study of a drug at the site of action and the EFFECT ON THE BODY. |
| Toxicology | study of harmful effects of chemicals including drugs, environment toxins, and poisons. |
| Graded Dose Respose Curve | *for 1 patient, used to determine the EC50 which is the dose in a patient that will result in half the EMax. |
| Potency | the more potent the drug requires lower dose to produce the same effect as a higher dose of a second drug, **determined by affinity for its receptor and the ability of the drug to reach its site of action., Only in 1 patient. |
| Efficacy | determined by type of interaction with receptor, and limitations on amount that can be administered, |
| EMax. | = max effect produced |
| Quantal Dose Response Curve | biological variability among people/populations, graphs Y |
| Hyperreactive | Pt. need a very low dose before a response is seen. |
| Hyopreactive | Pt. need very high does before a response is seen. |
| Tolerance | Time related loss of resonse to a drug (weeks to months) |
| Idiosyncratic drug response | infrequently observed drug effect. Ex: 1 out of 300,000 people have some side effect. |
| Tachyphylaxis | Tolerance that happens very quickly (minutes to hours) |
| Hypersensitivity | allergic reaction to a drug. |
| Therapeutic Index | TD50/ED50 TD50=median toxic dose 50% of pop. exhibits adverse effects ED50= median effective dose 50% pop. responds in a specified manner. Indicator of drug safety, the greater the TI, the safer the drug. |
| Bioavailability | extent to which the drug reaches systemic circulation, get first pass effect of given orally, 100% if IV |
| Volume of Distribution | body space into which a drug can diffuse Ex: asprin only in bloodstream Vd=8.4L |
| Clearance | amount of blood or other fluids from which all drug is removed per unit time (steady state concentrations) |
| Half Life | dosing regimen to achieve steady state concentration of drug in blood, take half life x 4 |
| Absorption | dependent on: administration mode, product chemistry, disease state, drug interactions, first pass effect, and pH |
| Distribution | dependent on: drug charac's (lipid soluble, size, ionized), binding to plasma protein (only free drug can be transported), blood flow to tissues absent in abscesses or tumors, BBB, pass b/w capillaries |
| Metabolism | Phase I |
| Elimination | Filtration( protein binding, molecular size and charge), passive transport (dependent on pH & lipid solubility), active transport (requires ATP) |
| Receptors | proteins with unique binding sites inside cell or on surface, interact w/ endogenous and exogenous cmpds, interpret a signal from the drug and transfer that info into effect, middle man b/w drug and body. |
| Signal Transduction | 1.ligand binds to the receptor 2. receptor propagates a signal 3. proteins are turned on and mobilize 2nd messanger molecules to amplify signal 4. 2nd messangers active other proteins that carry the signal further 5. physiological response 6. termination |
| Second Messengers | take an external stimulus and turn it into a cellular response and allow for quick movement of a signal. |
| Drug Selectivity | related to both affinity and efficact, influences only 1 particular tissue and induces a specific response, side effects. |
| Affinity | refers to the attraction between a receptor and ligand. |
| Efficacy | refers to the ability of a ligand to bind to the receptr, activate it, and lead to some physiological response. |
| Agonist | a drug that binds to the receptor and causes a response |
| Antagonist | a drug that binds to the receptor without a response, BLOCKER! |